Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 610


An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.

Warren S, Partridge M, Bolsi A, Lomax AJ, Hurt C, Crosby T, Hawkins MA.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):199-207. doi: 10.1016/j.ijrobp.2016.01.044. Epub 2016 Jan 30.


Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.

Stützer K, Lin A, Kirk M, Lin L.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):738-749. doi: 10.1016/j.ijrobp.2017.06.017. Epub 2017 Jun 20.


Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.

Barten DL, Tol JP, Dahele M, Slotman BJ, Verbakel WF.

Med Phys. 2015 Nov;42(11):6589-98. doi: 10.1118/1.4933245.


Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.

Warren S, Hurt CN, Crosby T, Partridge M, Hawkins MA.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):729-737. doi: 10.1016/j.ijrobp.2017.07.025. Epub 2017 Jul 29.


Robust Proton Pencil Beam Scanning Treatment Planning for Rectal Cancer Radiation Therapy.

Blanco Kiely JP, White BM.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):208-15. doi: 10.1016/j.ijrobp.2016.02.037. Epub 2016 Feb 16.


Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.

Abbas AS, Moseley D, Kassam Z, Kim SM, Cho C.

J Appl Clin Med Phys. 2013 May 6;14(3):4269. doi: 10.1120/jacmp.v14i3.4269.


Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.

Inoue T, Widder J, van Dijk LV, Takegawa H, Koizumi M, Takashina M, Usui K, Kurokawa C, Sugimoto S, Saito AI, Sasai K, Van't Veld AA, Langendijk JA, Korevaar EW.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):661-9. doi: 10.1016/j.ijrobp.2016.06.2454. Epub 2016 Jun 29.


Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.

Yin L, Wu H, Gong J, Geng JH, Jiang F, Shi AH, Yu R, Li YH, Han SK, Xu B, Zhu GY.

World J Gastroenterol. 2012 Oct 7;18(37):5266-75. doi: 10.3748/wjg.v18.i37.5266.


Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.

Jensen MF, Hoffmann L, Petersen JBB, Møller DS, Alber M.

Med Phys. 2018 Oct;45(10):4355-4363. doi: 10.1002/mp.13139. Epub 2018 Sep 6.


Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.

Seco J, Gu G, Marcelos T, Kooy H, Willers H.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):188-94. doi: 10.1016/j.ijrobp.2013.04.048.


Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.

Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1336-42. doi: 10.1016/j.ijrobp.2010.07.2001. Epub 2011 Apr 4.


Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.

Kraan AC, van de Water S, Teguh DN, Al-Mamgani A, Madden T, Kooy HM, Heijmen BJ, Hoogeman MS.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):888-96. doi: 10.1016/j.ijrobp.2013.09.014. Epub 2013 Oct 25.


Evaluation of Robustness to Setup and Range Uncertainties for Head and Neck Patients Treated With Pencil Beam Scanning Proton Therapy.

Malyapa R, Lowe M, Bolsi A, Lomax AJ, Weber DC, Albertini F.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):154-62. doi: 10.1016/j.ijrobp.2016.02.016. Epub 2016 Feb 11.


18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.

Qiu J, Lv B, Fu M, Wang X, Zheng X, Zhuo W.

Head Neck. 2017 Dec;39(12):2519-2527. doi: 10.1002/hed.24925. Epub 2017 Sep 30.


Benchmarking of a treatment planning system for spot scanning proton therapy: comparison and analysis of robustness to setup errors of photon IMRT and proton SFUD treatment plans of base of skull meningioma.

Harding R, Trnková P, Weston SJ, Lilley J, Thompson CM, Short SC, Loughrey C, Cosgrove VP, Lomax AJ, Thwaites DI.

Med Phys. 2014 Nov;41(11):111710. doi: 10.1118/1.4897571.


4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.

Dong P, Lee P, Ruan D, Long T, Romeijn E, Low DA, Kupelian P, Abraham J, Yang Y, Sheng K.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):407-13. doi: 10.1016/j.ijrobp.2013.02.002. Epub 2013 Mar 21.


Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.

Liu W, Frank SJ, Li X, Li Y, Park PC, Dong L, Ronald Zhu X, Mohan R.

Med Phys. 2013 May;40(5):051711. doi: 10.1118/1.4801899.


Esophageal cancer dose escalation using a simultaneous integrated boost technique.

Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):468-74. doi: 10.1016/j.ijrobp.2010.10.023. Epub 2010 Dec 1.


Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.

Lin LL, Kirk M, Scholey J, Taku N, Kiely JB, White B, Both S.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):181-9. doi: 10.1016/j.ijrobp.2015.07.2205. Epub 2015 Jul 11.


Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.

Fakhrian K, Oechsner M, Kampfer S, Schuster T, Molls M, Geinitz H.

Strahlenther Onkol. 2013 Apr;189(4):293-300. doi: 10.1007/s00066-012-0297-7. Epub 2013 Feb 28.


Supplemental Content

Support Center